SCOTTSDALE, Ariz., March 28, 2018 (GLOBE NEWSWIRE) -- Airware Labs Corporation (OTC:AIRW) (“Airware” or the “Company”) today announced that its wholly-owned subsidiary BSSD Group, LLC, doing business as Item 9 Labs, was named among Arizona's 2018 ERRL Cup winners. Item 9 was awarded 1st place in the Indica and Sativa categories for the quality of their Vanilla Bean and Candyland cannabis flowers.
The ERRL Cup: Cannabis Awards Arizona is an annual festival and awards event held in January. Established in 2015, the ERRL Cup was created to help the Arizona medical patient community obtain safe access to clean and consistent medicine. Before the year’s awards festival starts, ERRL Cup representatives interview all local labs in Arizona to evaluate their machinery, skills and staff for possible testing for the ERRL Cup. ERRL Cup uses cannabinoid, pesticides, mold, growth regulators, terpenes & residual solvent testing on all participant submissions. The competition is open to every legal state dispensary and any MMJ Card Holder.
Bryce Skalla, Co-Founder & CEO of Item 9 Labs, commented, “We are pleased and honored to be named as a 1st place winner in two categories at the prestigious ERRL Cup. This awards competition was created by patients for the benefit of the medical community, to evaluate and determine the best Cannabis medicine in the state of Arizona. To be recognized in a single category is an accomplishment, but to be awarded 1st place out of 400 entries in two distinct categories truly speaks to the excellence of our Cannabis strains. I would like to thank the ERRL Cup for this recognition as it underlines our commitment to providing patients with the highest quality medical-grade products.”
Item 9 Labs owns the largest approved manufacturing and cultivation area in the U.S. with 50 acres in Southern Arizona. Currently, Item 9 is utilizing five acres and intends to implement the remaining 45 acres in accordance with its three-year strategic plan. The property includes a 10,000 square foot, state-of-the-art manufacturing facility with 10,000 square feet of additional capacity already under construction. The additional capacity will include a commercial kitchen for infused co-branded products. As part of its growth strategy, the Company is in the process of opening additional cultivation and extraction locations in Massachusetts.
About Item 9 Labs:
Item 9 Labs is an Arizona-based cannabis consulting company with a proven record of high quality medical marijuana flower and products focused on organic cost-effective solutions for whole body health. Item 9 Labs owns and operates 50 acres in Southern Arizona, the largest property zoned to grow and cultivate the medical marijuana flower. Many cannabis manufacturers have moved their focus to hydroponic techniques that utilize harsh chemicals and nutrients, hindering the bioavailability of their product. Item 9 Labs maintains plant derived natural soil media and nutrient regiments, which it believes generates a superior product through enhanced taste, smell, and effect increasing customer demand. As a direct result of these organic farming techniques, Item 9 Labs' medicine sells at a price that is 5-10% higher than its state competitors.
About Airware Labs Corporation:
Airware Labs Corp's products are patented and address key consumer health and quality of life challenges including intra-nasal delivery of drugs and therapeutic oils. Airware products provide relief from snoring, insomnia, nausea, headaches, airborne bacteria and viruses, allergies and congestion. The Airware lineup also includes sports performance products. Unlike external products such as nasal strips, these soft, comfortable, and discreet, latex and drug free products fit just inside the nose utilizing an FDA approved medical grade material. Nearly invisible for use anytime and anywhere, the Airware Labs products' microstructure enhances normal nasal airflow with every breath. Some Airware products include 3M filtration media to stop allergens, airborne bacteria and viruses as well as a blend of proven, therapeutic premium oils to provide additional antimicrobial protection and symptomatic relief.
Airware Labs previously announced the availability of its Airware Defense product in South Korea marking another milestone in its growing success in expanding product sales in international as well as domestic markets. Airware Labs announced prestigious retail outlets in India and China are now selling Airware Labs' products. Domestically, the Company's pioneering products are available through a number of brick and mortar retail locations including Walgreens, Albertsons, Acme, Shoppers, Shop n' Save, ACME, and Farm Fresh along with individual distributors in the United States, Canada, and Europe. Online the products are available at a variety of retail sites including Walmart, Walgreens, Target, Drugstore.com, CVS, Amazon and Airware Labs Corp.
Airware Labs Corp. (publicly traded as OTC: AIRW) provides patented, innovative breathing and intra-nasal deliver technology products that promote better health and enhanced wellbeing. The company is headquartered in Scottsdale, Arizona. Explore our extensive product line at http://www.airwarelabs.com and learn more about our company by visiting http://airwarelabscorp.com.
Forward-Looking Statement: The statements in this press release regarding any implied or perceived benefits from the release by Airware Labs Corp. of its products and matters involving or proposed with Item 9 Labs are forward-looking statements. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, proposed transactions that are not legally binding obligations of the company and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. Information related to Item 9 Labs has been provided directly by Item 9 Labs and Airware Labs Corp. has not independently verified any of the information provided. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Media Contact:
Investor Relations:
Jeffrey Rassás
(480)463-4246 or (877)876-4868
Email: jeffrey@airwarelabs.com
Investor Contact:
Scott Eckstein
KCSA Strategic Communications
seckstein@kcsa.com
212-896-1210